Baculovirus Expression System Market Poised for Significant Growth, Estimate to Hit USD 781.8 Million by 2032 | Coherent Market Insights
Burlingame, CA, Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- The global Baculovirus Expression System Market is estimated to be valued at USD 436.0 Mn in 2025 and is expected to reach USD 781.8 Mn in 2032, exhibiting a compound annual growth rate ( CAGR ) of 8.7% from 2025 to 2032.
Bio-Rad ( BIO ) Q2 EPS Jumps 51%
Bio-Rad Laboratories ( NYSE:BIO ) , a global leader in life science research and clinical diagnostics, posted its second quarter 2025 financial results on July 31, 2025. The most important news was a clear earnings and revenue beat: Adjusted earnings per share ( non-GAAP ) were $2.61 in Q2 2025, ...
Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings - Bio-Rad Laboratories ( NYSE:BIO )
Bio-Rad Laboratories, Inc. BIO reported better-than-expected second-quarter financial results on Thursday. Bio-Rad Laboratories reported quarterly earnings of $2.61 per share which beat the analyst consensus estimate of $1.76 per share.
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday - Rich Sparkle Holdings ( NASDAQ:ANPA ) , AppFolio ( NASDAQ:APPF )
U.S. stocks were lower, with the Dow Jones index falling around 500 points on Friday. Shares of Monolithic Power Systems, Inc. MPWR rose sharply during Friday's session after the company reported better-than-expected second-quarter financial results and issued third-quarter sales guidance above ...
Earnings Preview: Bio-Rad Laboratories ( BIO ) Q2 Earnings Expected to Decline
Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In Situ Hybridization Market is expected to generate a revenue of USD 3.38 Billion by 2031, Globally, at 8.97% CAGR: Verified Market Research®
Lewes, Delaware, July 14, 2025 ( GLOBE NEWSWIRE ) -- The Global In Situ Hybridization Market Size is projected to grow at a CAGR of 8.97% from 2024 to 2031, according to a new report published by Verified Market Research®.
Bio-Rad Stock Climbs Following the Launch of Four ddPCR Platforms
BIO surges 4% as the Stilla acquisition fuels the launch of four ddPCR systems, expanding to 400K+ assay offerings.
Genomics Market to Hit US$66.8 Billion by 2029 with 9.4% CAGR | MarketsandMarkets™.
Delray Beach, FL, June 11, 2025 ( GLOBE NEWSWIRE ) -- The global genomics market, valued at US$42.4 billion in 2023, stood at US$42.6 billion in 2024 and is projected to advance at a resilient CAGR of 9.4% from 2024 to 2029, culminating in a forecasted valuation of US$66.8 billion by the end of ...
Biomarker Market is expected to generate a revenue of USD 130.16 Billion by 2032, Globally, at 13.77% CAGR: Verified Market Research®
Lewes, Delaware, June 04, 2025 ( GLOBE NEWSWIRE ) -- The Global Biomarker Market Size is projected to grow at a CAGR of 13.77% from 2026 to 2032, according to a new report published by Verified Market Research®.
Cardiac Marker Market Size Projected to Reach USD 28.27 billion by 2031 at a 13.2% CAGR | The Insight Partners
US & Canada, May 28, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the cardiac marker market is witnessing significant growth owing to the rising prevalence of Cardiovascular diseases ( CVDs ) and growing technological advancements in diagnostic ...
Digital PCR and Real-Time PCR Market Size Worth USD 17.54 billion by 2031 at 9.1% CAGR | The Insight Partners
US & Canada, May 19, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the global digital PCR and real-time PCR market is witnessing substantial growth with the surging incidence of genetic and infectious diseases and rising investments in gene ...
Investing in Bio-Rad ( BIO ) ? Don't Miss Assessing Its International Revenue Trends
Explore Bio-Rad's (BIO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket
Bio-Rad witnesses first-quarter top-line decline in its Life Science segment, primarily due to challenges in the academic research market.
Bio-Rad Laboratories ( BIO ) Q1 Earnings Surpass Estimates
Bio-Rad (BIO) delivered earnings and revenue surprises of 46.82% and 0.05%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Point of Care Diagnostics Market Size to Reach $82.95 Bn by 2028 Globally, at 12.7% CAGR: The Insight Partners
US & Canada, April 28, 2025 ( GLOBE NEWSWIRE ) -- As per a new, comprehensive report from The Insight Partners, the Point of Care Diagnostics Market is experiencing significant growth owing to increasing incidences of infectious diseases.
Analysts Estimate Bio-Rad Laboratories ( BIO ) to Report a Decline in Earnings: What to Look Out for
Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer ( aNSCLC ) was supported by Biodesix, using Bio-Rad Droplet Digital™ PCR technology Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer ( aNSCLC ) was ...
Bioprocess Optimization and Digital Bio-manufacturing Market Forecast 2029
Boston, April 04, 2025 ( GLOBE NEWSWIRE ) -- According to the latest study from BCC Research, "Bioprocess Optimization and Digital Bio-manufacturing: Global Markets" is expected to grow from $24.3 billion in 2024 to $39.6 billion by the end of 2029 at a compound annual growth rate ( CAGR ) of ...
Infectious Disease Diagnostics Market Size to Reach USD 59.95 Million by 2030, Driven by Technological Advancements and Rising Disease Prevalence - The Insight Partners
US & Canada, April 04, 2025 ( GLOBE NEWSWIRE ) -- According to a comprehensive report from The Insight Partners, "Infectious Disease Diagnostics Market Size and Forecasts ( 2020 - 2030 ) , Global and Regional Share, Trends, and Growth Opportunity Analysis By Product ( Kits & Reagents, ...
Should You Continue to Hold Bio-Rad Stock in Your Portfolio?
BIO continues to attract investors' attention due to its robust performance in the ddPCR platform.
Microcarriers Market Size Set to Expand to USD 4.17 Billion by 2030, Driven by Cell Therapy Demand and Strategic Innovations - The Insight Partners
US & Canada, March 28, 2025 ( GLOBE NEWSWIRE ) -- US & Canada, Mar, 21, 2025 ( GlobeNewswire ) -- According to a comprehensive report from The Insight Partners, "Microcarriers Market Size and Forecasts ( 2020 - 2030 ) , Global and Regional Share, Trends, and Growth Opportunity Analysis", The ...
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
Oncocyte Reports Successful 2024. Sets Stage for 2025 Catalysts ...
Newborn Screening Market Size to Reach US$ 2.69 billion by 2031, Growing at a CAGR of 9.5%, Says The Insight Partners
US & Canada, March 24, 2025 ( GLOBE NEWSWIRE ) -- US & Canada, Mar, 24, 2025 ( GlobeNewswire ) -- According to a comprehensive report from The Insight Partners, "Newborn Screening Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report", The newborn ...
$6.7 Billion Laboratory Consumables Market by 2034: Growth in Germany, Belgium, and Netherlands Fueled by Increasing R&D Investments - Analysis by TMR
Wilmington, Delaware, Transparency Market Research Inc. -, March 11, 2025 ( GLOBE NEWSWIRE ) -- The laboratory consumables market in Germany, Belgium, and the Netherlands is witnessing significant growth, fueled by rising R&D investments, technological advancements, and expanding biotech ...
Global Microbiological Testing of Water Market to Reach $2.3 Billion by 2027, Dominated by Tech Giants 3M ( US ) , Thermo Fisher Scientific Inc. ( US ) , and Danaher Corporation ( US )
Delray Beach, FL, March 04, 2025 ( GLOBE NEWSWIRE ) -- The global microbiological testing of water market is projected to grow significantly, reaching an estimated $2.3 billion by 2027 at a compound annual growth rate ( CAGR ) of 7.4%.
Protection Reagents Market is Expected to Reach at US$ 329.0 Million by 2035, Exhibiting 5.5% CAGR | Fact.MR Analysis
Rockville, MD , March 04, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the Protection Reagents Market was valued at US$ 182.6 million in 2024 and is expected to grow at a CAGR of 5.5% during the forecast period of 2025 to 2035.
Bio-Rad ( BIO ) International Revenue Performance Explored
Review Bio-Rad's (BIO) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
HSIC Q4 Earnings Match Estimates, Margins Up, Stock Falls in Premarket
Henry Schein's fourth-quarter results reflect stable dental and medical end-markets.
Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat
VCYT registers robust growth from its market-leading Decipher Prostate and Afirma tests.
Globus Medical Q4 Earnings & Revenues Top, Margins Expand, Stock Dips
GMED's fourth-quarter 2024 performance reflects strong synergies from the NuVasive merger.
EXAS Q4 Loss Narrower Than Expected, Stock Falls, Revenues Up Y/Y
Exact Sciences' fourth-quarter 2024 performance benefits from the robust momentum in Cologuard adoption.
Penumbra Q4 Earnings & Revenues Top, Margins Expand, Stock Rises
Penumbra reports better-than-expected earnings and revenues in the fourth quarter of 2024.
Medtronic Q3 Earnings Top Estimates, Revenues Miss, Stock Tumbles
MDT delivers strong earnings in the fiscal 2025 third quarter, with significant improvements in both gross and operating margins.
BIO Stock Might Rise Following the Offer to Acquire Stilla
Bio-Rad offers to acquire all equity interests of Stilla Technology. The acquisition is expected to complement Bio-Rad's existing digital PCR portfolio.
BIO Q4 Earnings and Revenues Miss Estimates, Stock Down Aftermarket
Bio-Rad witnesses growth across the Clinical Diagnostics segment in the fourth quarter, primarily driven by an increased demand for quality control and blood typing products.
Bruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls
Bruker delivers better-than-expected earnings and revenues in the fourth quarter of 2024.
Bio-Rad Laboratories ( BIO ) Misses Q4 Earnings and Revenue Estimates
Bio-Rad (BIO) delivered earnings and revenue surprises of -1.02% and 1.07%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
CVS Health Stock Up on Q4 Earnings & Revenue Beat, Margins Rise
CVS tops earnings and revenue estimates in the fourth quarter of 2024 amid macroeconomic impacts in the Health Care Benefits arm.
Oncocyte Prices $29.1 Million Equity Offering
• Proceeds Expected to Fund Transplant Assay Through FDA IVD Clearance and Commercial Launch
Omnicell Q4 Earnings & Revenues Beat, Stock Up, Gross Margin Rises
OMCL returns to year-over-year revenue growth in the fourth quarter of 2024.
QIAGEN Q4 Earnings Miss, Stock Crashes, Margins Expand
QGEN's performance benefits from a resilient portfolio in the fourth quarter of 2024.
PAHC Stock Falls Despite Q2 Earnings & Revenue Beat, Margins Increase
Phibro's second-quarter fiscal 2025 results reflect the strong performance of the legacy Animal Health business.
Earnings Preview: Bio-Rad Laboratories ( BIO ) Q4 Earnings Expected to Decline
Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Labcorp Q4 Earnings & Revenues Beat, Margins Down, Stock Tumbles
LH delivers better-than-expected revenues and earnings in the fourth quarter of 2024.
Hologic Q1 Earnings Beat, Stock Falls on Dismal '25 Sales Guidance
HOLX's fiscal 2025 first-quarter results reflect the strength of its Molecular Diagnostics business.
BSX Q4 Earnings & Revenues Top, Stock Falls on Weak Gross Margin
Boston Scientific's fourth-quarter 2024 performance reflects the strength of its core franchises.
Has BioRad Laboratories ( BIO ) Outpaced Other Medical Stocks This Year?
Here is how Bio-Rad Laboratories (BIO) and Certara, Inc. (CERT) have performed compared to their sector so far this year.
Microplate Reader Market to Reach USD 916.8 Million by 2031, Fueled by Rising Investments in Drug Discovery and Biopharmaceutical Research
US & Canada, Feb. 03, 2025 ( GLOBE NEWSWIRE ) -- According to a comprehensive report from The Insight Partners, "Microplate Reader Market Size and Forecast ( 2023 - 2031 ) , Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type ( Single-Mode Microplate ...
RNA Transcriptome Profiling Tests Market Expands at 14.5% CAGR, Surpassing US$ 37 Billion by 2034 | Fact.MR Report
Rockville, MD, Jan. 20, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global RNA transcriptome profiling test market is estimated to reach a valuation of US$ 9,652.2 million in 2024 and is expected to grow at a CAGR of 14.5% during ...
Is Adaptive Biotechnologies ( ADPT ) Stock Outpacing Its Medical Peers This Year?
Here is how Adaptive Biotechnologies (ADPT) and Bio-Rad Laboratories (BIO) have performed compared to their sector so far this year.
